A surprising finding from a comprehensive European cohort study reveals an often-overlooked diabetes risk group: individuals who develop type 2 diabetes despite maintaining normal body weight. Representing 5% of diabetes cases tracked across European populations from 2000-2024, this lean diabetes subgroup progresses rapidly and challenges the assumption that weight is the primary determinant of diabetes risk.
This discovery emerged from analysis of 18,567 adults whose metabolic changes were monitored for 5-10 years before diabetes diagnosis. The lean diabetes pathway demonstrates that metabolic dysfunction and beta-cell failure can occur independently of obesity, suggesting that screening protocols and risk stratification tools must expand beyond anthropometric measurements.
Clinicians and public health officials now recognize that individuals with normal BMI may still require intensive metabolic monitoring, particularly those showing other markers of metabolic dysfunction. This finding underscores the importance of comprehensive metabolic assessment rather than reliance on weight-based risk assessment alone in diabetes prevention programs.
Read the full article on GMJ Newsroom.
Was this article helpful?
